Acacia Capital Partners, Pond Ventures and Intel Capital support TV receiver Mirics.
Category: Sectors
Joyent adds Layerboom Systems to its cloud
Intel Capital-backed Joyent bolts on software company Layerboom.
Intel reaps $160m windfall from Smart flotation
Intel Capital sells initial tranche of 10 million shares in Canada-based education equipment provider Smart Technologies’ flotation.
NVP joins IDG and Accel in India
Norwest Venture Partners joins venture peers in backing India-based Perfint Healthcare.
Brennan joins Vitae Pharma
Former head of strategy and operations for strategic alliances at Switzerland-based drugs company Novartis’ Institutes for BioMedical Research joins venture-backed Vitae Pharmaceuticals.
Intel sees positive gains from equity investing
Record results for semiconductor maker shows spring back in venturing portfolio.
GE sets up $200m clean-tech fund
General Electric jointly funds its third corporate venturing fund with support from four venture capital groups.
Naspers buys a chunk of Digital Sky
Russian internet group gains full control of Mail.ru and $388m in cash for selling 28.7% of itself to South Africa’s Naspers.
Intel’s Callaghan leads Irish innovation fund
Ireland follows UK in forming fund of venture capital funds with India planning direct investment vehicle for its pharmaceutical industry.
Drakelid moves to vice chairman of Odyssey Pictures
Founder of Sweden-based venture capital firm Siguiente Capital steps up role at US-based media and marketing company Odyssey Pictures.
JJDC-backed Ventus Medical raises $40m
Series D round for US medical devices company Ventus Medical boosts funding for Stanford lecturer.
Jivox eyes strategic investors for next funding round
Indian serial entrepreneur Diaz Nesamoney’s latest venture, Jivox, looks to double its funding to $30m next year.
ASI gains $10m in latest funding round
Advanced Inquiry Systems sees support for at least corporate venturing units for series C round.
Novo backs Reata Pharmaceuticals’ $78m round
Denmark-based Novo, which has as one of the largest and most influential corporate venturing units by Global Corporate Venturing in June, is one of two co-leaders in diabetes company Reata’s $78m investment round.